Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elevate-CKD
jRCT2041260109Recruiting
- Sponsor
- AstraZeneca
- Start
- Aug 2026
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in chronic kidney disease (CKD) comparing Elecoglipron with Placebo (2 arms). Started Aug 2026; status: recruiting.
02
Drugs
elecoglipron
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT2041260109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2041260109.